Suppression of FOXO1 attenuates inflamm‐aging and improves liver function during aging
Aging Cell · 2023-10 · 22 (10)
DOI: 10.1111/acel.13968 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 21.08.2023. Verfasst von Wanbao Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, Texas, USA. Hauptthemen laut MEDLINE: Fatty Liver, Glucose Intolerance. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIA NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The liver is a key metabolic organ that maintains whole‐body nutrient homeostasis. Aging‐induced liver function alterations contribute to systemic susceptibility to aging‐related diseases. However, the molecular mechanisms of liver aging remain insufficiently understood. In this study, we performed bulk RNA‐Seq and single‐cell RNA‐Seq analyses to investigate the underlying mechanisms of the aging‐induced liver function changes. We found that liver inflammation, glucose intolerance, and liver fat deposition were aggravated in old mice. Aging significantly increased pro‐inflammation in hepatic macrophages. Furthermore, we found that Kupffer cells (KCs) were the major driver to induce pro‐inflammation in hepatic macrophages during aging. In KCs, aging significantly increased pro‐inflammatory levels; in monocyte‐derived macrophages (MDMs), aging had a limited effect on pro‐inflammation but led to a functional quiescence in antigen presentation and phagosome process. In addition, we identified an aging‐responsive KC‐specific (ARKC) gene set that potentially mediates aging‐induced pro‐inflammation in KCs. Interestingly, FOXO1 activity was significantly increased in the liver of old mice. FOXO1 inhibition by AS1842856 significantly alleviated glucose intolerance, hepatic steatosis, and systemic inflammation in old mice. FOXO1 inhibition significantly attenuated aging‐induced pro‐inflammation in KCs partially through downregulation of ARKC genes. However, FOXO1 inhibition had a limited effect on aging‐induced functional quiescence in MDMs. These results indicate that aging induces pro‐inflammation in liver mainly through targeting KCs and FOXO1 is a key player in aging‐induced pro‐inflammation in KCs. Thus, FOXO1 could be a potential therapeutic target for the treatment of age‐associated chronic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, Texas, USA.
- Department of Statistics, Texas A&M University, College Station, Texas, USA.
- Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, Texas, USA.
- High Performance Research Computing, Texas A&M University, College Station, Texas, USA.
ORCID-Profile: Wanbao Yang, Shaodong Guo
Förderung
- NIDDK NIH HHS
- NIA NIH HHS
- National Institutes of Health
Zitieren
APA
Yang, W., Kim, D. M., Jiang, W., Ai, W., Pan, Q., Rahman, S., Cai, J. J., Brashear, W. A., Sun, Y., & Guo, S. (2023). Suppression of FOXO1 attenuates inflamm‐aging and improves liver function during aging. Aging Cell, 22(10). https://doi.org/10.1111/acel.13968
Vancouver
Yang W, Kim DM, Jiang W, Ai W, Pan Q, Rahman S, et al. Suppression of FOXO1 attenuates inflamm‐aging and improves liver function during aging. Aging Cell. 2023;22(10). doi:10.1111/acel.13968
BibTeX
@article{Yang2023,
author = {Yang, Wanbao and Kim, Da Mi and Jiang, Wen and Ai, Weiqi and Pan, Quan and Rahman, Shahina and Cai, James J and Brashear, Wesley A and Sun, Yuxiang and Guo, Shaodong},
title = {Suppression of FOXO1 attenuates inflamm‐aging and improves liver function during aging},
journal = {Aging Cell},
year = {2023},
volume = {22},
number = {10},
doi = {10.1111/acel.13968}
}
EUVIMED